In Vitro Efficacy of ARQ 092, an Allosteric AKT Inhibitor, on Primary Fibroblast Cells Derived From Patients With PIK3CA-related Overgrowth Spectrum (PROS)

Neurogenetics - Germany
doi 10.1007/s10048-018-0540-1
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Molecular and Functional Characterization of Three Different Postzygotic Mutations in PIK3CA-Related Overgrowth Spectrum (PROS) Patients: Effects on PI3K/AKT/mTOR Signaling and Sensitivity to PIK3 Inhibitors

PLoS ONE
Multidisciplinary
2015English

One of the First Cases With PIK3CA-related Overgrowth Spectrum (PROS) in Saudi Arabia: A Case Report and Literature Review

Cureus
2020English

Preclinical Efficacy of Covalent-Allosteric AKT Inhibitor Borussertib in Combination With Trametinib in KRAS-mutant Pancreatic and Colorectal Cancer

Cancer Research
Cancer ResearchOncology
2019English

Rapid Isolation and Expansion of Skin-Derived Precursor Cells From Human Primary Fibroblast Cultures

Biology Open
BiochemistryAgriculturalGeneticsMolecular BiologyBiological Sciences
2017English

The Impact of Cetuximab Plus AKT- Or mTOR- Inhibitor in a Patient-Derived Colon Cancer Cell Model With Wild-Type RAS and PIK3CA Mutation

Journal of Cancer
Oncology
2017English

Biphasic Ability of Periosteum-Derived Cells Between Osteoblastgenesis and Fibroblast Genesis in Vitro

Clinical Oral Implants Research
Oral Surgery
2018English

Phase II Study of an AKT Inhibitor MK2206 in Patients With Relapsed or Refractory Lymphoma

Blood
BiochemistryImmunologyCell BiologyHematology
2014English

Metabolic Consequences of Treatment With AKT Inhibitor Perifosine in Breast Cancer Cells

NMR in Biomedicine
Nuclear MedicineRadiologyMolecular MedicineImagingSpectroscopy
2011English

Effects of Antifibroblast Antiserum on Cells Derived From Fibroblast Outgrowth of Human Prostatic Tissues

2000English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy